This publication reports on newly diagnosed cancers registered in England in addition to cancer deaths registered in England during 2020. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document.

This statistic shows the number of deaths from cervical cancer in England from 2014 to 2021. In 2021, the number of deaths from cervical cancer reached 702, an increase from 681 deaths in 2020.

In 2020, approximately 58 men and 43 women per 100,000 population died from lung cancer in England and Wales. During the provided time interval, there has been a noticeable decrease in the mortality of lung cancer among men, while the rate among women has remained at similar levels since the year 2000.

Cancer diagnoses and age-standardised incidence rates for all types of cancer by age and sex including breast, prostate, lung and colorectal cancer.

This statistic shows the rate of registrations of newly diagnosed cases of ovarian cancer per 100,000 population in England in 2020, by region. With a rate of 22.4 newly diagnosed females with ovarian cancer per 100,000 population in 2020, the regions most affected by ovarian cancer was North West.

The Get Data Out programme from the National Disease Registration Service publishes detailed statistics about small groups of cancer patients in a way that ensures patient anonymity is maintained. The Get Data Out programme currently covers 15 cancer sites. This data release updates the incidence data for all 15 sites to cover 2013-2020 (previous data covered 2013-2019) and also adds new cancer sites ‘Liver and biliary tract’, 'Haematological malignancies' and 'Haematological malignancy transformations'. The 18 cancer sites now covered by Get Data Out are: ‘Bladder, Urethra, Renal Pelvis and Ureter’, ‘Bone cancer’, ‘Brain, meningeal and other primary CNS tumours’, ‘Eye cancer’, 'Haematological malignancies', 'Haematological malignancy transformations', ‘Head and neck’, ‘Kaposi sarcoma’, ‘Kidney’, 'Liver and Biliary tract', ‘Oesophageal and Stomach’, ‘Ovary, fallopian tube and primary peritoneal carcinomas’, ‘Pancreas’, ‘Prostate’, ‘Sarcoma’, ‘Skin tumours’, ‘Soft tissue and peripheral nerve cancer’, ‘Testicular tumours including post-pubertal teratomas’. Anonymisation standards are designed into the data by aggregation at the outset. Patients diagnosed with a certain type of tumour are divided into many smaller groups, each of which contains approximately 100 patients with the same characteristics. These groups are aimed to be clinically meaningful and differ across cancer sites. For each group of patients, Get Data Out routinely publish statistics about incidence, routes to diagnosis, treatments and survival. All releases and documentation are available on the Get Data Out main technical page. Before using the data, we recommend that you read the guide for first time users. The data is available in an open format for anyone to access and use. We hope that by releasing anonymous detailed data like this we can help researchers, the public and patients themselves discover more about cancer. If you have feedback or any other queries about Get Data Out, please email us at NDRSenquires@nhs.net and mention 'Get Data Out' in your email.

This release summarises the diagnoses in 2019 registered by NDRS covering all registerable neoplasms (all cancers, all in situ tumours, some benign tumours and all tumours that have uncertain or unknown behaviours)

Update 2 March 2023: Following the merger of NHS Digital and NHS England on 1st February 2023 we are reviewing the future presentation of the NHS Outcomes Framework indicators. As part of this review, the annual publication which was due to be released in March 2023 has been delayed. Further announcements about this dataset will be made on this page in due course. Directly standardised mortality rate from cancer for people aged under 75, per 100,000 population. To ensure that the NHS is held to account for doing all that it can to prevent deaths from cancer in people under 75. Some different patterns have been observed in the 2020 mortality data which are likely to have been impacted by the coronavirus (COVID-19) pandemic. Statistics from this period should also be interpreted with care. Legacy unique identifier: P01733

One-year and five-year net survival for adults (15-99) in England diagnosed with one of 29 common cancers, by age and sex.

This statistic shows the rate of registrations of newly diagnosed cases of lung cancer per 100,000 population in England in 2020, by region and gender. With a rate of 100.8 newly diagnosed males with lung cancer and 90.8 females per 100,000 population in 2020, the region most affected by lung cancer was the North East.

This statistic shows the rate of registrations of newly diagnosed cases of prostate cancer per 100,000 population in England in 2020, by region. With a rate of 160.2 newly diagnosed males with prostate cancer per 100,000 population in 2020, the region most affected by prostate cancer was South East.

The cancer services profiles have been updated to split the existing indicator ‘Females, 25 to 64, attending cervical screening within target period (3.5 or 5.5 year coverage, %)’ by age group (25 to 49 and 50 to 64), creating 2 new and distinct indicators. All other indicators for the cancer services profile were released on 1 December 2020.

These profiles present data at GP, Clinical Commissioning Group (CCG) and national level on:

• cancer incidence and screening
• Two Week Wait (TWW) referrals
• diagnostic services
• emergency presentations and admissions

The https://fingertips.phe.org.uk/profile/cancerservices" class="govuk-link">cancer services profiles have been designed to support commissioners and health professionals to assess the impact of cancer on their local population and make decisions about services.

These profiles replace the GP cancer profiles that were previously presented in the Cancer Commissioning Toolkit.

Legacy unique identifier: P01733

This file contains the digital vector boundaries for Cancer Alliances in England, as at April 2020. The BGC boundaries are generalised (20m) - clipped to the coastline (Mean High Water mark). Contains both Ordnance Survey and ONS Intellectual Property Rights.REST URL of ArcGIS for INSPIRE View Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Cancer_Alliances_(April_2020)_GCB_EN/MapServerREST URL of ArcGIS for INSPIRE Feature DownloadService – https://dservices1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/services/Cancer_Alliances_April_2020_Generalised_Clipped_Boundaries_EN/WFSServer?service=wfs&request=getcapabilitiesREST URL of Feature Access Service – https://services1.arcgis.com/ESMARspQHYMw9BZ9/arcgis/rest/services/Cancer_Alliances_April_2020_GCB_EN_2022/FeatureServer

In 2021, 172.9 females per 100,000 population were registered in England as newly diagnosed with breast cancer. This was an overall increase in comparison to the last few years' rate of registration, and a steep rise from the drop in the rate of registration reported in 2020. This statistic shows the rate of newly diagnosed female cases of breast cancer per 100,000 population in England from 1995 to 2021.

Directly age standardised mortality rate from breast cancer for females in the respective time period per 100,000 registered female patients. March 2020: In addition to the changes in March 2019, the indicator production process has been fully automated. As a result there are two changes to this publication: 1) Data in this file are published for 2016-2018 only; all data is based on the most recent methodology. For the historic time series of this indicator please refer to the zip files in the June 2018 publication: https://digital.nhs.uk/data-and-information/publications/clinical-indicators/ccg-outcomes-indicator-set/archive/ccg-outcomes-indicator-set---june-2018 Please note, neither version of the file contains data for 2015-2017; changes in the data processing meant the 2015 data was not comparable to the 2016 and 2017 data processed under the new method. 2) Data are run against CCGs which were in existence at the time of processing. As of the March 2019 release the processing of the Primary Care Mortality Database (PCMD) and the standard population used to calculate the indicator for new data periods changed; this file now contains only those data periods processed under the new method. For the historic time series of this indicator please refer to the June 2018 publication referenced above. Legacy unique identifier: P01819